» Articles » PMID: 15245700

The Use of Oral Rehydration Solutions in Children and Adults

Overview
Specialty Gastroenterology
Date 2004 Jul 13
PMID 15245700
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The observation that the intestinal Na(+)-glucose cotransporter remains intact in most diarrheal illnesses led to development of the life-saving, low-cost technology of oral rehydration salt (ORS) solutions. The primary therapeutic role of ORS solutions is in prevention and treatment of dehydration during management of acute gastroenteritis. Successful oral rehydration therapy involves early use of ORS with maintenance or timely resumption of regular feeding. Since the inception of the oral rehydration approach more than three decades ago, the widespread use of ORS solutions has revolutionized the management and outcomes of acute gastroenteritis in children and adults. The efficacy of the World Health Organization ORS solution and of commercial ORS formulations has been enhanced by reducing osmolarity. Newer formulations of ORS are under active investigation, with promise of added benefits, including promotion of intestinal healing. This article reviews fluid and electrolyte transport in the gastrointestinal tract, the pathophysiologic mechanisms of acute diarrhea, and the basis and formulation of current and newer ORS solutions. Guidelines for efficacious use of ORS in the management of acute gastroenteritis and short gut syndrome are also provided.

Citing Articles

Oral rehydration solution (ORS) for fasting doping: Examining the Twitter data in Indonesia.

Kusuma I, Bahar M Narra J. 2024; 3(3):e196.

PMID: 38455632 PMC: 10919700. DOI: 10.52225/narra.v3i3.196.


Atypical organophosphate poisoning and a successful case of prolonged intubation in a low-resource newly developed intensive care unit in rural Zambia.

Bowell L, Williams M BMJ Case Rep. 2024; 17(2).

PMID: 38383128 PMC: 10882451. DOI: 10.1136/bcr-2022-253435.


Mg2+ supplementation treats secretory diarrhea in mice by activating calcium-sensing receptor in intestinal epithelial cells.

de Souza Goncalves L, Chu T, Master R, Chhetri P, Gao Q, Cil O J Clin Invest. 2023; 134(2).

PMID: 37962961 PMC: 10786700. DOI: 10.1172/JCI171249.


Safety of a Bioactive Polyphenol Dietary Supplement in Pediatric Subjects with Acute Diarrhoea.

Sarker S, Sultana S, Pietroni M, Dover A Int J Pediatr. 2015; 2015:387159.

PMID: 26435718 PMC: 4576009. DOI: 10.1155/2015/387159.


Secretory diarrhoea: mechanisms and emerging therapies.

Thiagarajah J, Donowitz M, Verkman A Nat Rev Gastroenterol Hepatol. 2015; 12(8):446-57.

PMID: 26122478 PMC: 4786374. DOI: 10.1038/nrgastro.2015.111.


References
1.
Aranda-Michel J, Giannella R . Acute diarrhea: a practical review. Am J Med. 1999; 106(6):670-6. PMC: 7124219. DOI: 10.1016/s0002-9343(99)00128-x. View

2.
Dutta D, Bhattacharya M, Deb A, Sarkar D, Chatterjee A, Biswas A . Evaluation of oral hypo-osmolar glucose-based and rice-based oral rehydration solutions in the treatment of cholera in children. Acta Paediatr. 2000; 89(7):787-90. View

3.
Hirschhorn N, Greenough 3rd W . Progress in oral rehydration therapy. Sci Am. 1991; 264(5):50-6. DOI: 10.1038/scientificamerican0591-50. View

4.
Alam N, Majumder R, FUCHS G . Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group. Lancet. 1999; 354(9175):296-9. DOI: 10.1016/s0140-6736(98)09332-5. View

5.
Ziegler T, Szeszycki E, Estivariz C, Puckett A, Leader L . Glutamine: from basic science to clinical applications. Nutrition. 1996; 12(11-12 Suppl):S68-70. DOI: 10.1016/s0899-9007(96)00019-6. View